Inspira Technologies Oxy B.H.N. Ltd. (IINN)
NASDAQ: IINN · Real-Time Price · USD
0.6101
+0.0703 (13.02%)
At close: May 30, 2025, 4:00 PM
0.5851
-0.0250 (-4.10%)
After-hours: May 30, 2025, 7:57 PM EDT

Company Description

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel.

It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.

The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N.

Ltd. in July 2020. Inspira Technologies Oxy B.H.N.

Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.

Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy B.H.N. logo
Country Israel
Founded 2018
IPO Date Jul 14, 2021
Industry Medical Devices
Sector Healthcare
Employees 45
CEO Dagi Ben-Noon

Contact Details

Address:
2 Ha-Tidhar St.
Ra'anana, 4366504
Israel
Phone 972 4 623 0333
Website inspira-technologies.com

Stock Details

Ticker Symbol IINN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $5.51
CIK Code 0001837493
CUSIP Number M53637100
ISIN Number IL0011715781
SIC Code 3841

Key Executives

Name Position
Dagi Shahar Ben-Noon Co-Founder, Chief Executive Officer and Director
Joe Hayon Co-Founder, President and Director
Yafit Tehila Chief Financial Officer
Avi Shabtai Chief Operating Officer and Vice President of Research and Development
Daniella Yeheskely-Hayon Ph.D. Chief Technology Officer
Sivan Ozeri Administrative Manager
Adi Shmueli Director of Marketing

Latest SEC Filings

Date Type Title
May 30, 2025 6-K Report of foreign issuer
May 29, 2025 6-K Report of foreign issuer
May 27, 2025 6-K Report of foreign issuer
May 15, 2025 SCHEDULE 13G/A Filing
May 15, 2025 SCHEDULE 13G/A Filing
May 12, 2025 6-K Report of foreign issuer
May 7, 2025 6-K Report of foreign issuer
Apr 23, 2025 6-K Report of foreign issuer
Apr 15, 2025 6-K Report of foreign issuer
Apr 10, 2025 6-K Report of foreign issuer